In the past few years, modular facilities or prefabricated buildings have emerged as a promising alternative to the conventionally built pharma / biotech manufacturing facilities. Modular manufacturing facility construction involves building of structures using prefabricated modular units, off-site, under controlled factory setting; these modular manufacturing units are later assembled on site. It is interesting to note that off-site construction can eliminate 60%-90% of the weather-related project concerns. Further, modular facilities can be built 40% faster as compared to a conventional construction, which could take up to three years. Therefore, considering the various advantages offered by this approach, several pharmaceutical players are now shifting their focus from conventional plants to modular manufacturing facilities. Specifically, modular facility providers are catering to the needs of various players engaged in the development of therapeutics, including cell and gene therapy, biosimilars and vaccines. To provide more context, modular biomanufacturing includes division of individual production processes, such as fermentation, purification and formulation, into separate modules that can be easily assembled and disassembled, allowing for flexibility and scalability. In addition, modular manufacturing allows the use of smaller-scale production units, which can be more flexible and responsive to dynamic market demands. Moreover, temporary modular buildings can be relocated after installation, based on needs of the end-user. However, mass production, complex decision-making, construction approvals and early financing can hinder the adoption of modular constructs. If healthcare stakeholders are able to overcome these challenges, modular construction can serve as a lucrative approach that provides greater flexibility and enables faster time-to-market for new products.
Key Market Insights
The Modular Manufacturing Facilities Market in Pharmaceutical and Biotechnology (3rd Edition) - Distribution by Size of Facility (Small, Mid-sized, Large and Very Large), Type of Industry Served (Pharmaceutical and Biotechnology), Type of Modular Construct (Hybrid Skid Modular Constructs, Skid-Mounted Modular Constructs, Plug-and-Play Modular Constructs, Truckable Modular Constructs and Other Modular Constructs), Type of Construction Component (Process Equipment, Base Building, Mechanical, Electrical and Plumbing System, Process Commodities and Other Construction Components), Purpose of Facility (Manufacturing Facilities, Aseptic Filling Facilities, Research and Development Facilities and Other Facilities), Scale of Operation (Clinical and Commercial), Type of Product (Cell and Gene Therapies, Vaccines, Biosimilars, Monoclonal Antibodies, Advanced Pharmaceuticals, Sterile Products, Viral Vectors and Other Products), Type of Expansion (New Facilities, Facility Expansions and Planned Expansions), Type of Modular Construction (Relocatable Modular Construction, Permanent Modular Construction), Type of Material Used (Steel, Wood and Concrete) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape and future opportunity, offering an informed opinion on the likely adoption of modular facilities in the pharmaceutical and biotechnology industries, over the next 12 years. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. The report answers the following key questions related to this domain.
Key Advantages Offered by Modular Facilities
Modular manufacturing facilities have emerged as a promising alternative to conventional facilities owing to the multiple benefits that they offer. For instance, modular facilities can help in achieving 25%-30% reduction in the overall cost of construction, minimal plant site interruption, 50%-60% faster construction timelines, as well as ensure portability, safe working conditions and sustainability. In addition, better quality of products can be achieved by modular construction approaches owing to the fact that modules are built in a controlled factory setting. In addition, these modules are inspected more thoroughly and frequently before they are shipped to the construction site meeting desired quality standards. Moreover, modular construction allows more flexibility in terms of design, as a higher number of materials and finishes can be used, as compared to conventional facilities.
Current Market Landscape of Modular Manufacturing Facilities
The modular facilities market landscape features an extensive list of over 50 large, mid-sized, small and very small players. It is worth highlighting that more than 250 players are engaged in offering modular cleanrooms, along with various cleanroom accessories and customization options, in order to make them suitable for application in the life sciences industry. It is expected that modular facilities will become more streamlined and standardized in the future, serving as an efficient cost saving solution. Additionally, modular techniques allow building of smaller and specialized processing plants whenever rapid deployment of a therapy becomes critical in both developed and developing countries. Further, many, if not most, expansions and new facilities in the pharmaceutical and biotechnology industry are likely to be modular constructions in the near future.
Key Drivers in the Modular Facilities Market
Over the past few years, several factors have contributed to reform the facility construction paradigm within the pharmaceutical and biotechnology industries. The increasing preference and demand for personalized therapies and novel therapeutic interventions intended for the treatment of various ailments has compelled pharmaceutical companies to look beyond the traditional manufacturing and expansion practices. Lack of adequate manufacturing infrastructure, increased cost of construction and delay in project deliveries has collectively contributed to the emergence of off-site construction models.
Overall Size of Modular Facilities Market
Driven by the rising interest of stakeholders towards improvement of manufacturing and production efficiency, the anticipated lucrative opportunities and growth associated with adoption of modular manufacturing facilities, this market is expected to witness noteworthy growth in the foreseen future. Specifically, in terms of type of product, the market is anticipated to be driven by manufacturing units for cell and gene therapies, as well as vaccines and biosimilars. In addition, presently, close to 70% of the market share is captured by players based in North America and Europe. However, in the long run, markets in emerging regions, such as countries based in Asia, MENA and rest of the world are anticipated to grow at a faster pace.
Example Players in the Modular Facilities Market
Examples of players engaged in this domain (which have also been profiled in this report) include (in alphabetical order) Cytiva, G-CON Manufacturing, Germfree, IPM Technologies, KeyPlants, ModuleCo Pharma, NNE and Pharmadule.
Scope of the Report
The study presents an in-depth analysis of the various firms / organizations that are engaged in this domain, across different segments.
The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:
- An executive summary of the key insights captured during our research, offering a high-level view on the current state of the modular facilities market and its likely evolution in the short to mid and long term.
- A brief introduction to important concepts related to modular facilities, featuring information on different types of modular constructs, as well as primary applications of modular facilities in the pharmaceutical and biotechnology domains. Further, this chapter highlights the recent advancements that have been reported in this market space.
- A detailed assessment of the current market landscape of modular facilities, highlighting the contributions of various service providers, along with information on their year of establishment, company size (small, mid-sized and large), location of headquarters (North America, Europe, Asia and rest of the world, type of industry served (pharmaceutical, biotechnology, other industries), geographical coverage (North America, Europe, Asia and rest of the world), GMP compliance, type of modular construction (relocatable, permanent), type of material (steel, wood and concrete) and quality certification(s) obtained.
- A detailed review of the overall landscape of the modular cleanroom providers market, highlighting the contributions of various players, along with information on their year of establishment, company size (small, mid-sized and large) , location of headquarters (North America, Europe, Asia, MENA and rest of the world), type of industry served (pharmaceutical, biotechnology), type of modular cleanroom offered (hardwall, softwall and unspecified), type of cleanroom component offered (air handling units, HEPA filters, ULPA filters, laminar air flow units, air showers, pass throughs, biosafety cabinets, cleanroom furniture, plumbing / piping, lighting / electrical, doors and windows) and quality certification(s) obtained.
- An in-depth company competitiveness analysis of modular facility service providers, segmented into three categories, namely small (2-50 employees), mid-sized (51-500 employees) and large (>500 employees) players. Within the respective peer groups, companies were ranked based on various relevant parameters, such as service strength (based on the years of experience), company competitiveness (based on parameters, such as type of industry served, GMP compliance, type of modular construction and type of material), as well as partnership activity (in terms of number of partnerships and type of agreements).
- Elaborate profiles of prominent players that are currently engaged in offering modular facilities. Each profile features a brief overview of the company (with information on year of establishment, number of employees, location of headquarters and key members of the executive team), details related to their respective service portfolio, recent developments and an informed future outlook.
- An analysis of the partnerships inked between various stakeholders in this domain, during the period 2012-2022, featuring a detailed set of analyses based on various parameters, such as year of partnership, type of partnership, type of product, type of modular facility, location of modular facility, geographical location of the companies involved and most active players.
- A detailed case study on modular projects undertaken by modular facility manufacturers in the pharmaceutical and biotechnology industry, along with information on type of modular facility, size of modular facility, number of projects delivered and location of modular facility.
- An insightful analysis on facility construction trends observed in the pharmaceutical industry over the last seven years, highlighting facility construction projects established by top 20 pharma / biotech players, along with the information on number of facilities, type of facility, purpose of facility, investments made in modular projects, size of facility and location of headquarters.
- An insightful framework that enables a thorough examination of the cost and time related offered by the use of different modular approaches, by considering multiple parameters, including long-term benefits and sustainability, to identify the most appropriate solution for various types of end users and enabling them to make informed decisions.
- A detailed market forecast analysis to estimate the existing market size and the future opportunity for modular facility manufacturers, till 2035; the overall opportunity has been distributed across various segments, such as size of facility (small, mid-sized, large and very large), type of industry served (pharmaceutical and biotechnology), type of modular construct (hybrid skid modular constructs, skid-mounted modular constructs, plug-and-play modular constructs, truckable modular constructs and other modular constructs), type of construction component (process equipment, base building, mechanical, electrical and plumbing system, process commodities and other construction components), purpose of facility (manufacturing facilities, aseptic filling facilities, research and development facilities and other facilities), scale of operation (clinical and commercial), type of product (cell and gene therapies, vaccines, biosimilars, monoclonal antibodies, advanced pharmaceuticals, sterile products, viral vectors and other products), type of expansion (new facilities, facility expansions and planned expansions), type of modular construction (relocatable modular construction, permanent modular construction), type of material (steel, wood and concrete) and key geographical regions (North America, Europe, Asia, Middle East And North Africa, and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
- A review of emerging industry trends, including the combination of single-use technologies / continuous processing technologies with modular facilities, the shift to using smaller, multi-purpose modular facilities, and technological advancements in modular construction processes.
- A detailed discussion on the various growth drivers, such as development of personalized medicines, biosimilars, orphan drugs and anticipated increase in the adoption of modular solutions in the emerging markets by pharmaceutical / biopharmaceutical CMOs.
The opinions and insights presented in the report were influenced by discussions held with senior stakeholders in the industry.
The report features detailed transcripts of interviews held with the following industry stakeholders:
- Maik Jornitz (Chief Executive Officer, G-CON Manufacturing)
- Pär Almhem (President, ModWave)
- Vernon Solomon (President, Environmental Systems Corporation)
- François Abiven (Ex-President Life Sciences and Chemicals, Exyte)
- Mark Koers (Executive Vice President, Sales and Marketing, Modular Devices)
- Luca Mussati (Vice President Pharmaceutical and Biotechnology, Exyte)
- Ward Patton (Director of Sales, Subzero Engineering)
- Wes Temple (Director of Marketing, Vernick)
- Sulogna Roy (Ex-Sales Manager, Zeton)
- Alan de Zayas (Modular Building Manufacturing and Construction Team, Avon Modular)
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Frequently Asked Questions
Question 1: What is modular manufacturing?
Answer: Modular facilities are prefabricated buildings that are built using multiple sections, often known as modules. To provide more context, modular constructs are designed, engineered and manufactured off-site, and later delivered to relevant project site for final installation. Further, integrated assemblies are joined together to create facilities of significant size, housing multiple functions and equipment.
Question 2: Which material is most widely used for the construction of modular facilities?
Answer: Steel and wood are the most commonly used materials for building pre-engineered builds. Of these, steel is usually employed to construct permanent buildings since they are built for use over longer periods of time. On the other hand, wood is generally more suitable for building relocatable constructs as the material is lightweight and hence, allows easy relocation.
Question 3: Which types of partnerships are being inked by modular facility providers?
Answer: Full facility construction agreements, service alliances and cleanroom construction agreements are the most common partnership models adopted by stakeholders engaged in the modular facilities domain.
Question 4: Which healthcare sector is rapidly employing modular facilities?
Answers: Currently, the pharmaceutical industry is leading the adoption of modular facilities in the healthcare sector. On the other hand, the modular facilities market for biotechnology industry is expected to grow at 11%, capturing a considerable market share in the foreseen future.
Question 5: How is the modular facilities market likely to grow in the future?
Answers: The global modular facilities market is anticipated to grow at a compound annualized growth rate of 10%, till 2035.
Question 6: Which region is leading the modular facilities market?
Answers: North America and Europe, combined, hold 70% share of the global modular facilities market. In the longer run, emerging regions, such as Asia, are likely to grow at faster pace.
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Historical Background
3.3. The Concept of Modular Facilities
3.3.1. Types of Modular Constructs
3.3.2. Modular Construction Process
3.4. Modular Construction in the Pharmaceutical Industry
3.4.1. Advantages of Modular Construction in the Pharmaceutical Industry
3.4.2. Modular Pharmaceutical Cleanrooms
3.4.2.1. Cleanroom Classifications and Current Standards
3.4.2.2. Regulations and Standards Concerning Modular Cleanroom Construction
3.5. Advantages of Modular Cleanrooms
3.6. Challenges and Future Prospects
4. MARKET LANDSCAPE: MODULAR FACILITY MANUFACTURERS
4.1. Chapter Overview
4.2. Modular Facility Manufacturers: Overall Market Landscape
4.2.1 Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Year of Establishment and Location of Headquarters
4.2.5. Analysis by Company Size and Location of Headquarters
4.2.6. Analysis by Type of Industry Served
4.2.7. Analysis by Geographical Coverage
4.2.8. Analysis by Type of Industry Served and Geographical Coverage
4.2.9. Analysis by GMP Compliance
4.2.10. Analysis by Geographical Coverage and GMP Compliance
4.2.11. Analysis by Type of Modular Construction
4.2.12. Analysis by Type of Industry Served and Type of Modular Construction
4.2.13. Analysis by Type of Material
4.2.14. Analysis by Type of Modular Construction and Type of Material
4.2.15. Analysis of Historical and Current Market Landscape Trends
4.2.15.1 Analysis by Company Size, Geographical Coverage and Type of Industry Served
5. MARKET LANDSCAPE: MODULAR CLEANROOM PROVIDERS
5.1. Chapter Overview
5.2. Modular Cleanroom Providers: Overall Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Year of Establishment and Location of Headquarters
5.2.5. Analysis by Company Size and Location of Headquarters
5.2.6. Analysis by Type of Industry Served
5.2.7. Analysis by Location of Headquarters and Type of Industry Served
5.2.8. Analysis by Type of Modular Cleanroom Offered
5.2.9. Analysis by Type of Industry Served and Type of Modular Cleanroom Offered
5.2.10. Analysis by Type of Cleanroom Component Offered
5.2.11. Analysis by Type of Industry Served and Cleanroom Component Offered
5.2.12. Analysis by Type of Modular Cleanroom and Cleanroom Component Offered
5.2.13. Analysis by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
5.2.14. Analysis by Quality Certifications Obtained
6. MODULAR FACILITY MANUFACTURERS: COMPANY COMPETITIVENESS ANALYSIS
6.1 Chapter Overview
6.2 Assumptions / Key Parameters
6.3 Methodology
6.4 Company Competitiveness Analysis: Modular Facility Manufacturers
6.4.1. Company Competitiveness Analysis: Benchmarking of Service Strength
6.4.2. Company Competitiveness Analysis: Benchmarking of Partnership activity
6.4.3. Company Competitiveness Analysis: Small Companies
6.4.4. Company Competitiveness Analysis: Mid-Sized Companies
6.4.5. Company Competitiveness Analysis: Large Companies
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Cytiva
7.2.1. Company Overview
7.2.2. Modular Facility-related Services
7.2.3. Modular Projects
7.2.4. Recent Developments and Future Outlook
7.3. G-CON Manufacturing
7.3.1. Company Overview
7.3.2. Modular Facility-related Services
7.3.3. Modular Projects
7.3.4. Recent Developments and Future Outlook
7.4. Germfree
7.4.1. Company Overview
7.4.2. Modular Facility-related Services
7.4.3. Modular Projects
7.4.4. Recent Developments and Future Outlook
7.5. IPM Technologies
7.5.1. Company Overview
7.5.2. Modular Facility-related Services
7.5.3. Modular Projects
7.5.4. Recent Developments and Future Outlook
7.6. KeyPlants
7.6.1. Company Overview
7.6.2. Modular Facility-related Services
7.6.3. Modular Projects
7.6.4. Recent Developments and Future Outlook
7.7. ModuleCo Pharma
7.7.1. Company Overview
7.7.2. Modular Facility-related Services
7.7.3. Modular Projects
7.7.4. Recent Developments and Future Outlook
7.8. NNE
7.8.1. Company Overview
7.8.2. Modular Facility-related Services
7.8.3. Modular Projects
7.8.4. Recent Developments and Future Outlook
7.9. Pharmadule
7.9.1. Company Overview
7.9.2. Modular Facility-related Services
7.9.3. Modular Projects
7.9.4. Recent Developments and Future Outlook
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Modular Facility Manufacturers: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year of Partnership and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Modular Facility
8.3.7. Analysis by Type of Product and Type of Modular Facility
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Location of Partner’s Headquarters
8.3.10. Analysis by Location of Modular Facility
8.3.11. Analysis by Type of Partnership and Location of Modular Facility
8.3.12. Analysis by Type of Product and Location of Modular Facility
8.3.13. Intercontinental and Intracontinental Partnerships
8.3.14. Analysis by Country
9. CASE STUDY ON MODULAR PROJECTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
9.1. Chapter Overview
9.2. Modular Facility Projects Undertaken in the Pharmaceutical and Biotechnology Industry
9.3.1. Analysis by Type of Modular Facility
9.3.2. Analysis by Size of Modular Facility
9.3.3. Most Active Manufacturers: Analysis by Number of Projects Delivered
9.3.4. Most Active Clients: Analysis by Number of Projects Received
9.3.5. Analysis by Location of Modular Facility
9.3.6. Analysis by Type of Facility and Size of Modular Facility
9.3.7. Analysis by Client and Location of Facility
10. FACILITY CONSTRUCTION TRENDS IN THE PHARMACEUTICAL INDUSTRY
10.1. Chapter Overview
10.2. Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry: Historical Data for Top 20 Players
10.2.1. Analysis by Number of Facilities Delivered
10.2.2. Analysis by Type of Facility
10.2.3. Analysis by Purpose of Facility
10.2.4. Analysis by Type of Facility and Purpose of Facility
10.2.5. Analysis by Type of Investment
10.2.6. Analysis by Purpose of Facility and Type of Investment
10.2.7. Analysis by Size of Facility
10.2.8. Analysis by Type of Facility and Size of Facility
10.2.9. Analysis by Purpose of Facility and Size of Facility
10.2.10. Analysis by Location of Headquarters
10.2.11. Analysis by Location of Facility
10.2.12. Analysis by Type of Facility and Location of Facility
11. COST-TIME OPTIMIZATION FRAMEWORK
11.1. Chapter Overview
11.2. Key Assumptions and Methodology
11.3. Factors Influencing Modular Construction
11.3.1. Intrinsic Factors
11.3.2. Extrinsic Factors
11.4. Cost Efficiency Analysis
11.5. Time-Benefit Analysis
11.6. Concluding Remarks
12. MARKET FORECAST
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Modular Facilities Market in the Pharmaceutical / Biotechnology Sector, 2023-2035
12.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Size of Facility, 2023 and 2035
12.4.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Small Facilities, 2023-203
12.4.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mid-sized Facilities, 2023-2035
12.4.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Large Facilities, 2023-2035
12.4.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Very Large Facilities, 2023-2035
12.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Industry Served, 2023 and 2035
12.5.1. Modular Facilities Market in the Pharmaceutical Industry, 2023-2035
12.5.2. Modular Facilities Market in the Biotechnology Industry, 2023-2035
12.6. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Modular Construct, 2023 and 2035
12.6.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Hybrid Skid Modular Constructs, 2023-2035
12.6.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Skid-Mounted Modular Constructs, 2023-2035
12.6.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Plug-and-Play Modular Constructs, 2023-2035
12.6.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Truckable Modular Constructs, 2023-2035
12.6.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Modular Constructs, 2023-2035
12.7. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Construction Component, 2023 and 2035
12.7.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Equipment, 2023-2035
12.7.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Base Buildings, 2023-2035
12.7.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mechanical, Electrical and Plumbing Systems, 2023-2035
12.7.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Commodities, 2023-2035
12.7.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Construction Components, 2023-2035
12.8 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Purpose of Facility, 2023 and 2035
12.8.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Manufacturing, 2023-2035
12.8.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Aseptic Filling, 2023-2035
12.8.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Research and Development, 2023-2035
12.8.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Purposes, 2023-2035
12.9. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Scale of Operation, 2023 and 2035
12.9.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Clinical Scale, 2023-2035
12.9.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Commercial Scale, 2023-2035
12.10. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Product, 2023 and 2035
12.10.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Cell and Gene Therapies, 2023-2035
12.10.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Vaccines, 2023-2035
12.10.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Biosimilars, 2023-2035
12.10.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Monoclonal Antibodies, 2023-2035
12.10.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Advanced Pharmaceuticals, 2023-2035
12.10.6. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Sterile Products, 2023-2035
12.10.7. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Viral Vectors, 2023-2035
12.10.8. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Products, 2023-2035
12.11. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Expansion, 2023 and 2035
12.11.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for New Facilities, 2023-2035
12.11.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Facility Expansions, 2023-2035
12.11.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Planned Expansions, 2023-2035
12.12. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Modular Construction, 2023 and 2035
12.12.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Relocatable Modular Construction, 2023-2035
12.12.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Permanent Modular Construction, 2023-2035
12.13. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Material 2023 and 2035
12.13.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Steel, 2023-2035
12.13.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Wood, 2023-2035
12.13.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Concrete, 2023-2035
12.14. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Geography, 2023 and 2035
12.14.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in North America, 2023-2035
12.14.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Europe, 2023-2035
12.14.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Asia, 2023-2035
12.14.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Middle East and North Africa, 2023-2035
12.14.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Rest of the World, 2023-2035
12.15. Concluding Remarks
13. PREVALENT AND EMERGING INDUSTRY TRENDS
13.1. Chapter Overview
13.2. Adoption of Modular Facilities
13.3. Expansion of Existing Service Portfolio
13.4. Integration of Advanced Technologies
13.4.1. Single-use Technologies
13.4.2. Continuous Processing Technologies
13.4.3. Other Advanced Technologies
14. FUTURE GROWTH OPPORTUNITIES
14.1. Chapter Overview
14.2. Visibility Amongst Start-Ups
14.3. Popularity Amongst Contract Manufacturing Organizations
14.4. Expansion of Existing Facilities
14.5. Adoption for Production of Biosimilars
14.6. Additional Opportunities
14.7. Key Growth Drivers for Modular Construction
14.8. Market Attractiveness in Emerging regions
15. CONCLUSION
16. EXECUTIVE INSIGHTS
16.1. Chapter Overview
16.2. Avon Modular
16.2.1. Company Snapshot
16.2.2. Interview Transcript: Alan de Zayas (Modular Building Manufacturing and Construction Team)
16.3. Environmental Systems Corporation
16.3.1. Company Snapshot
16.3.2. Interview Transcript: Vernon Solomon (President)
16.4. Exyte
16.4.1. Company Snapshot
16.4.2. Interview Transcript: François Abiven (Executive Vice President Global Business Unit BLS) and Luca Mussati (Vice President Technology and Innovation)
16.5. G-CON Manufacturing
16.5.1. Company Snapshot
16.5.2. Interview Transcript: Maik Jornitz (Chief Executive Officer)
16.6. Modular Devices
16.6.1. Company Snapshot
16.6.2. Interview Transcript: Mark Koers (Executive Vice President, Sales and Marketing)
16.7. ModWave
16.7.1. Company Snapshot
16.7.2. Interview Transcript: Pär Almhem (President)
16.8. Subzero Engineering
16.8.1. Company Snapshot
16.8.2. Interview Transcript: Ward Patton (Director of Sales)
16.9. Vernick
16.9.1. Company Snapshot
16.9.2. Interview Transcript: Wes Temple (Director of Marketing)
16.10. Zeton
16.10.1. Company Snapshot
16.10.2. Interview Transcript: Sulogna Roy (Ex-Sales Manager)
17. APPENDIX I: TABULATED DATA
18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION
List Of Figures
Figure 2.1 Executive Summary: Modular Facility Manufacturers
Figure 2.2 Executive Summary: Modular Cleanroom Providers
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry
Figure 2.5 Executive Summary: Facility Construction Trends in the Pharmaceutical Industry
Figure 2.6 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Modular Construction: Applications
Figure 3.2 Modular Construction: Processes Involved
Figure 3.3 Modular and Conventional Buildings: Construction Timeline
Figure 3.4 Modular Construction: Advantages
Figure 4.1 Modular Facility Manufacturers: Distribution by Year of Establishment
Figure 4.2 Modular Facility Manufacturers: Distribution by Company Size
Figure 4.3 Modular Facility Manufacturers: Distribution by Location of Headquarters
Figure 4.4 Modular Facility Manufacturers: Distribution by Year of Establishment and Location of Headquarters
Figure 4.5 Modular Facility Manufacturers: Distribution by Company Size and Location of Headquarters
Figure 4.6 Modular Facility Manufacturers: Distribution by Type of Industry Served
Figure 4.7 Modular Facility Manufacturers: Distribution by Geographical Coverage
Figure 4.8 Modular Facility Manufacturers: Distribution by Type of Industry Served and Geographical Coverage
Figure 4.9 Modular Facility Manufacturers: Distribution by GMP Compliance
Figure 4.10 Modular Facility Manufacturers: Distribution by Geographical Coverage and GMP Compliance
Figure 4.11 Modular Facility Manufacturers: Distribution by Type of Modular Construction
Figure 4.12 Modular Facility Manufacturers: Distribution by Type of Industry Served and Type of Modular Construction
Figure 4.13 Modular Facility Manufacturers: Distribution by Type of Material
Figure 4.14 Modular Facility Manufacturers: Distribution by Type of Modular Construction and Type of Material
Figure 4.15 Modular Facility Manufacturers: Distribution by Company Size, Geographical Coverage and Type of Industry Served
Figure 5.1 Modular Cleanroom Providers: Distribution by Year of Establishment
Figure 5.2 Modular Cleanroom Providers: Distribution by Company Size
Figure 5.3 Modular Cleanroom Providers: Distribution by Location of Headquarters
Figure 5.4 Modular Cleanroom Providers: Distribution by Year of Establishment and Location of Headquarters
Figure 5.5 Modular Cleanroom Providers: Distribution by Company Size and Location of Headquarters
Figure 5.6 Modular Cleanroom Providers: Distribution by Type of Industry Served
Figure 5.7 Modular Cleanroom Providers: Distribution by Type of Industry Served and Location of Headquarters
Figure 5.8 Modular Cleanroom Providers: Distribution by Type of Modular Cleanroom Offered
Figure 5.9 Modular Cleanroom Providers: Distribution by Type of Industry Served and Type of Modular Cleanroom Offered
Figure 5.10 Modular Cleanroom Providers: Distribution by Type of Cleanroom Component Offered
Figure 5.11 Modular Cleanroom Providers: Distribution by Type of Industry Served and Cleanroom Component Offered
Figure 5.12 Modular Cleanroom Providers: Distribution by Type of Modular Cleanroom and Cleanroom Component Offered
Figure 5.13 Modular Cleanroom Providers: Distribution by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
Figure 5.14 Modular Cleanroom Providers: Distribution by Quality Certifications Obtained
Figure 6.1 Company Competitiveness Analysis: Benchmarking of Service Strength
Figure 6.2 Company Competitiveness Analysis: Benchmarking of Partnership Activity
Figure 6.3 Company Competitiveness Analysis: Small Companies
Figure 6.4 Company Competitiveness Analysis: Mid-sized Companies
Figure 6.5 Company Competitiveness Analysis: Large Companies
Figure 7.1 Cytiva: Stages of KUBio Facility Project
Figure 7.2 Germfree: Types of Lab Modules
Figure 7.3 IPM Technologies: Features of ISOdule Units
Figure 7.4 IPM Technologies: Applications of Modular Facilities
Figure 7.5 KeyPlants: Modular Facility-related Services
Figure 7.6 NNE: Modular Facility-related Services
Figure 7.7 NNE: Benefits of Bio on Demand Facility
Figure 7.8 Pharmadule: Modular Facility Services
Figure 7.9 Pharmadule: Process of Modular Facility Construction
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2012-2022
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
Figure 8.4 Partnerships and Collaborations: Distribution by Type of Product
Figure 8.5 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
Figure 8.6 Partnerships and Collaborations: Distribution by Type of Modular Facility
Figure 8.7 Partnerships and Collaborations: Distribution by Type of Product and Type of Modular Facility
Figure 8.8 Most Active Players: Distribution by Number of Partnerships
Figure 8.9 Partnerships and Collaborations: Distribution by Location of Partner’s Headquarters
Figure 8.10 Partnerships and Collaborations: Distribution by Location of Modular Facility
Figure 8.11 Partnerships and Collaborations: Distribution by Type of Partnership and Location of Modular Facility
Figure 8.12 Partnerships and Collaborations: Distribution by Type of Product and Location of Modular Facility
Figure 8.13 Intercontinental and Intracontinental Partnerships
Figure 8.14 Partnerships and Collaborations: Country-wise Distribution
Figure 9.1 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Type of Modular Facility
Figure 9.2 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Size of Modular Facility
Figure 9.3 Most Active Manufacturers: Distribution by Number of Projects Delivered
Figure 9.4 Most Active Clients: Distribution by Number of Projects Received
Figure 9.5 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Location of Modular Facility
Figure 9.6 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Type of Facility and Size of Modular Facility
Figure 9.7 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Client and Location of Facility
Figure 9.8 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Modular versus Conventional Construction Methods
Figure 9.9 Modular and Conventional Facilities: Comparison of Construction Timelines
Figure 9.10 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: KUBio Facility Construction Process
Figure 9.11 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: KUBio Facility Construction Timeline
Figure 10.1 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Number of Facilities Delivered
Figure 10.2 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility
Figure 10.3 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility
Figure 10.4 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Purpose of Facility
Figure 10.5 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Investment
Figure 10.6 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility and Type of Investment
Figure 10.7 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Size of Facility
Figure 10.8 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Size of Facility
Figure 10.9 Facility Construction Trends in the Pharmaceutical Industry: Purpose of Facility and Size of Facility
Figure 10.10 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Headquarters
Figure 10.11 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Facility
Figure 10.12 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Location of Facility
Figure 11.1 Cost Efficiency Analysis: Comparison of Intrinsic Factors
Figure 11.2 Cost Efficiency Analysis: Comparison of Extrinsic Factors
Figure 11.3 Time-Benefit Analysis: Comparison of Intrinsic Factors
Figure 11.4 Time-Benefit Analysis: Comparison of Extrinsic Factors
Figure 11.5 Cost-Time Optimization Analysis: Overall Evaluation
Figure 12.1 Global Modular Facilities Market in the Pharmaceutical / Biotechnology Sector, 2023-2035 (USD Million)
Figure 12.2 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Size of Facility, 2023 and 2035
Figure 12.3 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Small Facilities, 2023-2035 (USD Million)
Figure 12.4 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mid-sized Facilities, 2023-2035 (USD Million)
Figure 12.5 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Large Facilities, 2023-2035 (USD Million)
Figure 12.6 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Very Large Facilities, 2023-2035 (USD Million)
Figure 12.7 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Industry Served, 2023 and 2035
Figure 12.8 Modular Facilities Market in the Pharmaceutical Industry, 2023-2035 (USD Million)
Figure 12.9 Modular Facilities Market in the Biotechnology Industry, 2023-2035 (USD Million)
Figure 12.10 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Modular Construct, 2023 and 2035
Figure 12.11 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Hybrid Skid Modular Constructs, 2023-2035 (USD Million)
Figure 12.12 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Skid-Mounted Modular Constructs, 2023-2035 (USD Million)
Figure 12.13 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Plug-and-Play Modular Constructs, 2023-2035 (USD Million)
Figure 12.14 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Truckable Modular Constructs, 2023-2035 (USD Million)
Figure 12.15 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Modular Constructs, 2023-2035 (USD Million)
Figure 12.16 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Construction Component, 2023 and 2035
Figure 12.17 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Equipment, 2023-2035 (USD Million)
Figure 12.18 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Base Building, 2023-2035 (USD Million)
Figure 12.19 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mechanical, Electrical and Plumbing System, 2023-2035 (USD Million)
Figure 12.20 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Commodities, 2023-2035 (USD Million)
Figure 12.21 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Construction Components, 2023-2035 (USD Million)
Figure 12.22 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Purpose of Facility, 2023 and 2035
Figure 12.23 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Manufacturing Facilities, 2023-2035 (USD Million)
Figure 12.24 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Aseptic Filling Facilities, 2023-2035 (USD Million)
Figure 12.25 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Research and Development Facilities, 2023-2035 (USD Million)
Figure 12.26. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Facilities, 2023-2035 (USD Million)
Figure 12.27 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Scale of Operation, 2023 and 2035
Figure 12.28 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Clinical Operations, 2023-2035 (USD Million)
Figure 12.29 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Commercial Operations, 2023-2035 (USD Million)
Figure 12.30 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Product, 2023 and 2035
Figure 12.31 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Cell and Gene Therapies, 2023-2035 (USD Million)
Figure 12.32 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Vaccines, 2023-2035 (USD Million)
Figure 12.33 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Biosimilars, 2023-2035 (USD Million)
Figure 12.34 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Monoclonal Antibodies, 2023-2035 (USD Million)
Figure 12.35 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Advanced Pharmaceuticals, 2023-2035 (USD Million)
Figure 12.36 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Sterile Products, 2023-2035 (USD Million)
Figure 12.37 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Viral Vectors, 2023-2035 (USD Million)
Figure 12.38 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Products, 2023-2035 (USD Million)
Figure 12.39 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Expansion, 2023 and 2035
Figure 12.40 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for New Facilities, 2023-2035 (USD Million)
Figure 12.41 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Facility Expansions, 2023-2035 (USD Million)
Figure 12.42 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Planned Expansions, 2023-2035 (USD Million)
Figure 12.43 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Modular Construction, 2023 and 2035
Figure 12.44 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Relocatable Modular Construction, 2023-2035 (USD Million)
Figure 12.45 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Permanent Modular Construction, 2023-2035 (USD Million)
Figure 12.46 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Material 2023 and 2035
Figure 12.47 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Steel, 2023-2035 (USD Million)
Figure 12.48 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Wood, 2023-2035 (USD Million)
Figure 12.49 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Concrete, 2023-2035 (USD Million)
Figure 12.50 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Geography, 2023 and 2035
Figure 12.51 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in North America, 2023-2035 (USD Million)
Figure 12.52 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Europe, 2023-2035 (USD Million)
Figure 12.53 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Asia, 2023-2035 (USD Million)
Figure 12.54 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Middle East and North Africa, 2023-2035 (USD Million)
Figure 12.55 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Rest of the World, 2023-2035 (USD Million)
Figure 13.1 Modular Facilities: Technological Advancements
Figure 14.1 Modular Facilities Market: Future Growth Opportunities
Figure 15.1 Concluding Remarks: Modular Facility Manufacturers Market Landscape
Figure 15.2 Concluding Remarks: Modular Cleanroom Providers Market Landscape
Figure 15.3 Concluding Remarks: Company Competitiveness Analysis
Figure 15.4 Concluding Remarks: Partnerships and Collaborations
Figure 15.5 Concluding Remarks: Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry
Figure 15.6 Concluding Remarks: Facility Construction Trends in Pharmaceutical Industry
Figure 15.7 Concluding Remarks: Publisher Framework
Figure 15.8 Concluding Remarks: Market Forecast
List Of Tables
Table 3.1 Cleanroom Classification Standards
Table 3.2 ISO and FED STD 209E: Cleanroom Classification
Table 4.1 Modular Facility Manufacturers: List of Service Providers
Table 4.2 Modular Facility Manufacturers: Information on Type of Industry Served, GMP Compliant Construction and Geographical Coverage
Table 4.3 Modular Facility Manufacturers: Information on Type of Modular Construction and Type of Material
Table 4.4 Modular Facility Manufacturers: List of Quality Certifications Obtained
Table 5.1 Modular Cleanroom Providers: List of Companies
Table 5.2 Modular Cleanroom Providers: Type of Industry Served
Table 5.3 Modular Cleanroom Providers: Type of Modular Cleanroom Offered
Table 5.4 Modular Cleanroom Providers: Type of Cleanroom Component Offered
Table 5.5 Modular Cleanroom Providers: List of Regulatory Approvals and Certifications Obtained
Table 6.1 Company Competitiveness Analysis: Benchmarking of Service Strength
Table 6.2 Company Competitiveness Analysis: Benchmarking of Partnership Activity
Table 6.3 Company Competitiveness Analysis: List of Small players
Table 6.4 Company Competitiveness Analysis: List of Mid-sized players
Table 6.5 Company Competitiveness Analysis: List of Large players
Table 7.1 List of Companies Profiled
Table 7.2 Cytiva: Key Highlights
Table 7.3 Cytiva: Modular Facility-Related Services
Table 7.4 Cytiva: Single-Use Technology Portfolio
Table 7.5 Cytiva: Modular Projects
Table 7.6 Cytiva: Recent Developments and Future Outlook
Table 7.7 G-CON Manufacturing: Key Highlights
Table 7.8 G-CON Manufacturing: Modular Facility-Related Services
Table 7.9 G-CON Manufacturing: Modular Projects
Table 7.10 G-CON Manufacturing: Recent Developments and Future Outlook
Table 7.11 Germfree Laboratories: Key Highlights
Table 7.12 Germfree Laboratories: Modular Facility-Related Services
Table 7.13 Germfree Laboratories: Key Features of Modules
Table 7.14 Germfree Laboratories: Recent Developments and Future Outlook
Table 7.15 IPM Technologies: Key Highlights
Table 7.16 IPM Technologies: Types of Modular Production Units
Table 7.17 KeyPlants: Key Highlights
Table 7.18 KeyPlants: Recent Developments and Future Outlook
Table 7.19 ModuleCo Pharma: Key Highlights
Table 7.20 ModuleCo Pharma: Key Features of Modular Facilities
Table 7.21 NNE: Key Highlights
Table 7.22 NNE: Modular Projects
Table 7.23 NNE: Recent Developments and Future Outlook
Table 7.24 Pharmadule: Key Highlights
Table 7.25 Pharmadule: Modular Projects
Table 7.26 Pharmadule: Recent Developments and Future Outlook
Table 8.1 Modular Facility Manufacturers: List of Partnerships and Collaborations, 2012-2022
Table 8.2 Modular Facility Manufacturers: List of Partnerships and Collaborations, Information on Type of Agreement 2012-2022
Table 9.1 Modular Facilities: List of Modular Projects
Table 9.2 Modular Facilities and Conventional Facilities: Comparison of Construction Investment and Financial Returns
Table 10.1 Conventional Facilities: Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry (Top 20 Companies): Historical Data, January 2016-2022
Table 10.2 Conventional Facilities: Information on Location of Headquarters, Area of Facility and Size of Facility
Table 16.1 Avon Modular: Company Snapshot
Table 16.2. Environmental Systems Corporation: Company Snapshot
Table 16.3 Exyte: Company Snapshot
Table 16.4 G-CON Manufacturing: Company Snapshot
Table 16.5 Modular Devices: Company Snapshot
Table 16.6 ModWave: Company Snapshot
Table 16.7 Subzero Simplex Cleanrooms: Company Snapshot
Table 16.8 Vernick Cleanroom Design and Construction: Company Snapshot
Table 16.9 Zeton: Company Snapshot
Table 17.1 Modular Facility Manufacturers: Distribution by Year of Establishment
Table 17.2 Modular Facility Manufacturers: Distribution by Company Size
Table 17.3 Modular Facility Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 17.4 Modular Facility Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 17.5 Modular Facility Manufacturers: Distribution by Year of Establishment and Location of Headquarters
Table 17.6 Modular Facility Manufacturers: Distribution by Company Size and Location of Headquarters
Table 17.7 Modular Facility Manufacturers: Distribution by Type of Industry Served
Table 17.8 Modular Facility Manufacturers: Distribution by Geographical Coverage
Table 17.9 Modular Facility Manufacturers: Distribution by Type of Industry Served and Geographical Coverage
Table 17.10 Modular Facility Manufacturers: Distribution by GMP Compliance
Table 17.11 Modular Facility Manufacturers: Distribution by Geographical Coverage and GMP Compliance
Table 17.12 Modular Facility Manufacturers: Distribution by Type of Modular Construction
Table 17.13 Modular Facility Manufacturers: Distribution by Type of Industry Served and Type of Modular Construction
Table 17.14 Modular Facility Manufacturers: Distribution by Type of Material
Table 17.15 Modular Facility Manufacturers: Distribution by Type of Modular Construction and Type of Material
Table 17.16 Modular Facility Manufacturers: Distribution by Company Size, Geographical Coverage and Type of Industry Served
Table 17.17 Modular Facility Manufacturers: Distribution by Quality Certifications Obtained
Table 17.18 Modular Cleanroom Providers: Distribution by Year of Establishment
Table 17.19 Modular Cleanroom Providers: Distribution by Company Size
Table 17.20 Modular Cleanroom Providers: Distribution by Location of Headquarters (Region-wise)
Table 17.21 Modular Cleanroom Providers: Distribution by Location of Headquarters (Country-wise)
Table 17.22 Modular Cleanroom Providers: Distribution by Year of Establishment and Location of Headquarters
Table 17.23 Modular Cleanroom Providers: Distribution by Company Size and Location of Headquarters
Table 17.24 Modular Cleanroom Providers: Distribution by Type of Industry Served
Table 17.25 Modular Cleanroom Providers: Distribution by Type of Industry Served and Location of Headquarters
Table 17.26 Modular Cleanroom Providers: Distribution by Type of Modular Cleanroom Offered
Table 17.27 Modular Cleanroom Providers: Distribution by Type of Industry Served and Type of Modular Cleanroom Offered
Table 17.28 Modular Cleanroom Providers: Distribution by Type of Cleanroom Component Offered
Table 17.29 Modular Cleanroom Providers: Distribution by Type of Industry Served and Cleanroom Component Offered
Table 17.30 Modular Cleanroom Providers: Distribution by Type of Modular Cleanroom and Cleanroom Component Offered
Table 17.31 Modular Cleanroom Providers: Distribution by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
Table 17.32 Modular Cleanroom Providers: Distribution by Quality Certifications Obtained
Table 17.33 Partnerships and Collaborations: Cumulative Year-wise Trend, 2012-2022
Table 17.34 Partnerships and Collaborations: Distribution by Type of Partnership
Table 17.35 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
Table 17.36 Partnerships and Collaborations: Distribution by Type of Product
Table 17.37 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
Table 17.38 Partnerships and Collaborations: Distribution by Type of Modular Facility
Table 17.39 Partnerships and Collaborations: Distribution by Type of Product and Type of Modular Facility
Table 17.40 Most Active Players: Distribution by Number of Partnerships
Table 17.41 Partnerships and Collaborations: Distribution by Location of Partner’s Headquarters
Table 17.42 Partnerships and Collaborations: Distribution by Location of Modular Facility
Table 17.43 Partnerships and Collaborations: Distribution by Type of Partnership and Location of Modular Facility
Table 17.44 Partnerships and Collaborations: Distribution by Type of Product and Location of Modular Facility
Table 17.45 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Table 17.46 Partnerships and Collaborations: Location of Headquarters (Country-wise) Distribution
Table 17.47 Modular Facilities: Distribution by Type of Modular Facility
Table 17.48 Modular Facilities: Distribution by Size of Facility
Table 17.49 Most Active Manufacturers: Distribution by Number of Projects Delivered
Table 17.50 Most Active Clients: Distribution by Number of Projects Received
Table 17.51 Modular Facilities: Distribution by Location of Modular Facility
Table 17.52 Modular Facilities: Distribution by Type of Facility and Size of Modular Facility
Table 17.53 Modular Facilities: Distribution by Client and Location of Facility
Table 17.54 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Number of Facilities Delivered
Table 17.55 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility
Table 17.56 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility
Table 17.57 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Purpose of Facility
Table 17.58 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Investment
Table 17.59 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility and Type of Investment
Table 17.60 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Size of Facility
Table 17.61 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Size of Facility
Table 17.62 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility and Size of Facility
Table 17.63 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Headquarters
Table 17.64 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Facility
Table 17.65 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Location of Facility
Table 17.66 Global Modular Facilities Market in the Pharmaceutical / Biotechnology Sector, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 17.67 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Size of Facility, 2023 and 2035
Table 17.68 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Small Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.69 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mid-sized Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.70 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Large Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.71 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Very Large Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.72 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Industry Served, 2023 and 2035
Table 17.73 Modular Facilities Market in the Pharmaceutical Industry, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.74 Modular Facilities Market in the Biotechnology Industry, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.75 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Modular Construct, 2023 and 2035
Table 17.76 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Hybrid Skid Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.77 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Skid-Mounted Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.78 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Plug-and-Play Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.79 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Truckable Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.80 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.81 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Construction Component, 2023 and 2035
Table 17.82 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Equipment, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.83 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Base Building, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.84 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mechanical, Electrical and Plumbing System, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.85 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Commodities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.86 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Construction Components, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.87 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Purpose of Facility, 2023 and 2035
Table 17.88 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Manufacturing Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.89 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Aseptic Filling Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.90 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Research and Development Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.91 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Facilities, 2023-2035, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.92 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Scale of Operation, 2023 and 2035
Table 17.93 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Clinical Operations, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.94 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Commercial Operations, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.95 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Product, 2023 and 2035
Table 17.96 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Cell and Gene Therapies, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.97 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Vaccines, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.98 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Biosimilars, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.99 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Monoclonal Antibodies, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.100 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Advanced Pharmaceuticals, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.101 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Sterile Products, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.102 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Viral Vectors, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.103 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Products, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.104 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Expansion, 2023 and 2035
Table 17.105 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for New Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.106 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Facility Expansions, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.107 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Planned Expansions, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.108 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Modular Construction, 2023 and 2035
Table 17.109 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Relocatable Modular Construction, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.110 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Permanent Modular Construction, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.111 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Material 2023 and 2035
Table 17.112 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Steel, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.113 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Wood, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.114 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Concrete, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.115 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Geography, 2023 and 2035
Table 17.116 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in North America, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.117 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Europe, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.118 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Asia, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.119 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Middle East and North Africa, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.120 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Rest of the World, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 209Technologies
- 3P Biopharmaceuticals
- A.D. Clean Rooms
- Ab Biotechnology
- Abbott
- AbbVie
- ABN Cleanroom Technology
- Abtech
- Abzena
- ACH Engineering
- ACIC Machinery
- ACME Cleanroom Technologies
- Acumen Technology
- Adamson Pharma
- ADC Biotechnology
- ADK Modulraum
- AdvanceTEC
- AES Clean Technology
- Air Micron Cleantech
- Aircare Projects
- Airgas
- AirKey
- Airology
- Airplan
- Airtech Systems
- Ajinomoto
- Albian Group
- Alfa PEB
- Allied Cleanrooms
- AM Technical Solutions
- American Cleanroom Systems
- Amgen
- Amicron Cleantech
- Amperox
- Angstrom Technology
- Anker Projects
- APsystems
- Aprotech
- Ardmac
- Asgard Cleanroom Solutions
- AstraZeneca
- Atmos Tech Industries
- Autolus Therapeutics
- AveXis
- Avid Bioservices
- Avon Modular
- AWS Bio-Pharma Technologies
- Axenic Systems
- B. Braun Medical
- Balaji CleanAir Solutions
- Bangalore Air Tech Solution
- Bassaire
- Baxter
- Bayer
- BC Technology
- BeiGene
- Belcher Equipment
- bioBUBBLE
- Biocatalysts
- Bio Clean Integrated Air System
- BioCon Solutions
- Biofactory Competence Center
- Biogen
- Biologics Modular
- BM Engineering
- Bode Equipment
- Boehringer Ingelheim
- BOXX Modular
- Brammer Bio
- Bristol Myers Squibb
- Build It
- Butler Manufacturing
- Calitech Technical Services
- Cambridge Cleanroom
- Can-Trol Environmental
- Caron
- C-Cube
- CE Group
- CGT Catapult Stevenage
- Chemgineering
- Chempharm
- Chrisleen Cleanroom Projects
- CoCID Associates
- Cipharm
- Clean Air Flow
- Clean Air Products
- Clean Air Systems
- Clean Air Technology
- Clean3 Modular Cleanroom Systems
- Clean Modules
- Clean Room Depot
- Clean Rooms International
- Clean Rooms Plus
- Clean Rooms West
- Clean Zone Technology
- CleanAir Solutions
- Cleanetics
- Cleanroom Ceiling Systems
- Cleanroom Combination Group
- Cleanroom Equipment
- Cleanroom Solutions
- Cleanroom Synergy
- Cleanrooms Australia
- Cleanrooms By United
- Cleanrooms Containments
- Cleanrooms Plus
- CleanSpace
- CleanZones
- ClearSphere
- Clenviron Technologies
- Clestra Hauserman
- Clestra Cleanroom
- Codiak BioSciences
- Commercial Structures corporation
- Connect 2 Cleanrooms
- CONSAB International
- Cotaplan
- CRB
- CRDB Modular Cleanroom Solutions
- Creative Foam
- Cytiva
- CytoImmune Therapeutics
- Dagard
- Daldrop
- Dawson Group
- Dec Group
- Design Filtration Microzone
- Dexcom
- Dozie and Dozie’s Pharma
- DPR Construction
- Drees & Sommer
- E- Pack Polymers
- Ebtech Industrial Modular Building Solutions
- Eli Lilly
- Emergent BioSolutions
- Enbloc
- Envair Electrodyne
- Environmental Systems Corporation
- Envision Biotech
- EPACK Prefab
- Erytech Pharma
- ESS Modular
- Everest Composites
- Expression Therapeutics
- Extract Technology
- Exyte
- Fabtech
- Ferring Pharnmaceuticals
- Filtration Technology
- Firmament Technology
- Firs Bioengineering
- Florida Cleanroom Systems
- Flowstar Corporation
- Fluor
- FOSELEV
- Galderma
- Gallant Technologies
- G-Con Manufacturing
- GenCure
- Genentech
- Gerbig Engineering Company
- Germfree
- Gilead Sciences
- GlaxoSmithKline
- GMP Technical Solutions
- GMPMax Pharma
- Green Carrier Consultancy and Tech Solutions
- GreenTech Venture
- Grekon Infratech
- Grifols
- GSK
- Guardtech Cleanrooms
- Halco Products
- HAZE comfort
- Hectra Enviro Systems
- Hemair Systems
- HEMCO
- HEPAire Products
- Hermetel Oy
- Hexakore
- Hodess Construction
- HOK
- Holden
- Hume Group MC
- Huntair
- Iberconcept
- ICT Innovative Cleanroom Technologies
- Iguna Pharmaceutical Technologies
- Ingelyt
- Innovation Expert Cleanrooms
- Innovative Cleanroom Technologies
- Innovative Pharmaintech
- Innovators Cleantech
- Instant Cleanroom Solutions
- Instaspace
- Instituto Butantan
- Intact
- Integrated Cleanroom Technologies
- Integrity Cleanroom
- IPM Technologies
- IPS
- IsoTech Design
- Jacobs
- JHL Biotech
- Johnson & Johnson
- Just Biotherapeutics
- Just-Evotec Biologics
- KABTech Corporation
- Kaizen Airtech Solutions
- Karlsruhe Institute of Technology
- KELVIN
- KeyPlants
- Kingspan
- Kleanzone Systems
- Klimapharm Technologies
- KTEC Cleanroom Systems
- L7 Informatics
- Lab in Boxes
- Labover
- LabRum
- Labworks International
- Lacy Construction
- Lasco Services
- Lennox Clean Air Technologies
- Libbs Farmacêutica
- Liberty Industries
- LifeAire Systems
- Lindner
- Linesight
- LM Air Technology
- Longden Company
- Lonza
- LSB La Salle Blanche
- MAK Clean Air Systems
- Marion VA Medical Center
- Mars Sterile Solutions
- McLennan & Company
- M. Davis & Sons
- MDI
- MECART
- Medical Air Technology
- Merck
- Merit Holdings
- Microbinc
- MicroCool
- MobileLabCompany
- Modubuild
- Moduguard
- Modular Cleanrooms
- Modular Devices
- Modular Panel Systems
- ModuleCo Pharma
- Modulus Cleanrooms
- Monmouth Scientific
- MRC Cleanrooms
- MRC Systems
- MTX Contracts
- Nano Clean
- National Cancer Institute
- National Institutes of Health
- National Partitions
- NCI Clean
- NGS Cleanroom Solutions
- Nicomac
- NNE
- Norwood Group
- Novartis
- Novo Nordisk
- OCTANORM
- Octapharma
- Ori Biotech
- Ortner Cleanrooms Unlimited
- Oxford BioMedica
- Pacific Environmental Technologies
- Pall Biotech
- Panel Built
- Panelco
- WSP
- Parteco
- PCCA
- Pentec Health
- Perotech Sciences
- Pfizer
- Pharma Access
- Pharma Air Control Engineers
- Pharma Air Modular Systems
- Pharmacon
- Pharmadule
- Pharmaintech Turnkey Solutions
- Piramal Pharma Solutions
- Plascore
- PortaFab
- Porta-King Building Systems
- Power And Motion
- PPG Cleanrooms
- Precise Engineering
- Precision Air Technology
- Precision Cleanrooms
- Precision Extraction Solutions
- ProCleanroom
- Propart Modular
- ProPharma Cleanrooms
- Protech Solutions
- Puracore
- PureLinc Cleanrooms
- Purever Tech
- QleanAir Scandinavia
- Riddhi Metals
- Rinac
- Ritterwand
- Robert Soper
- Roche
- Rubius Therapeutics
- Saakvee Technologies
- Sai Seva Service
- Sam Air Solution
- Sanofi
- Sapphire Cleanrooms
- Saudi Bio
- Schering Plough
- Schilling Engineering
- SciMed
- SD Consulting
- SGS
- Shanghai HJ Modular Cleanroom
- Shanghai Junshi Biosciences
- SIC Experts
- Siemens
- Simplex Isolation Systems
- Skanska
- Skylark Engineering Technologies
- SML Clean Room Solutions
- SP Groups
- Span Construction and Engineering
- Speed Space
- Srprefabs Modular Cleanroom
- Starrco
- Stefatos
- Steriltech
- STERIS Life Sciences
- Stodec Products
- Stragen Pharma
- Strike Bio
- Subzero Engineering
- Swedish Modules
- Syntec Airflow System
- System Integration Technology
- Systems BD
- SZ Airkey Environmental Tech & Eng
- Taiyo Pharma Tech
- Takeda
- Technical Air Products
- Telstar Life Science Solutions
- Terra Universal
- Zhejiang Teruisi Pharmaceutical
- TEVA Pharmceutical
- The Softwall Shop
- Thrius Pharma Expertize
- Total Precision Cleanrooms Aust
- Touchlight
- Travis CleanAir
- CTriumph Modular
- TrueBinding
- Tudela International
- Ultrapure Technology
- Unibio
- UNIFIED Technical Solutions
- Unikelvin Ventures
- United Partition Systems
- Univercells
- Universal Technical Solutions
- University of Tennessee Health Science Center
- Unizima
- Vanrx Pharmasystems
- Vedaa Prefab Technologies
- Veltek Associates
- Vernick
- Viessmann Technologies
- Vitma Positech
- VK Clean Rooms
- VRP Cleanroom Systems
- W.W. Cannon
- Wacker Chemie
- Walvax
- Weaver Technologies
- Westbury Cleanrooms
- Western Environmental Corporation
- Whitenair Technologies
- WHP Engineering
- WuXi Vaccines
- Xytel
- YRS Enterprise
- Zeton
- Ziccum
Methodology
LOADING...
